An analysis of ocular features and vision loss at presentation and after treatment in systemic lupus erythematosus in 60 patients
Journal Title: International Journal of Medical Research and Review - Year 2016, Vol 4, Issue 5
Abstract
Introduction: Systemic lupus erythematosus (SLE) is a chronic, inflammatory, multisystem autoimmune disease and ocular involvement occurs in several forms. It may be the first indicator of underlying SLE. Early identification and precise treatment of the disease can reduce blindness. The objective of this study was to analyze the causes of visual loss before and during treatment. Methods: This is a retrospective cohort study on 60 patients over 2 years in multispecialty, tertiary eye care hospital. Ophthalmic examination and routine and ancillary investigations were performed. Patients were followed up for at least one year to assess the progress of ocular features, their response to treatment and development of complications. Case records from a referral practice in patients with systemic lupus erythematosus, with diagnosis of dry eye, peripheral ulcerative keratitis, episcleritis, scleritis, uveitis, retinitis or optic neuropathy were analyzed. Results: In our study, the incidence of episcleritis was most frequent followed by dry eye, retinopathy and keratitis. Age group affected was 34 to 52 years and more in women. Scleritis was associated with decreased vision and maximum complications. Following treatment, cataract was the commonest cause of blindness. Conclusion: Our study showed the presence of simultaneous, multiple ocular complications which make treatment and follow up very crucial to avoid blindness. Ocular signs that occurs in SLE can be vision threatening and requires immediate assessment and management by an ophthalmologist. Drugs used to treat SLE may also cause blindness and coordinated treatment between rheumatologist, physician and ophthalmologist needs to be adopted.
Authors and Affiliations
M. Shantha Sruthi, Radha Annamalai, Muthayya Muthukumar
Serum homocysteine levels and the risk of Osteoporosis
Introduction: Osteoporosis is a major health problem which has devastating health consequences through its association with osteoporotic fractures. Prevention of osteoporosis by identifying the risk factors is a major ch...
Unicentric castleman’s disease of neck node in old age- rare presentation of a rare disease
Castleman’s disease is an uncommon lymphoproliferative disorder that may be unicentric or multicentric disease. We are reporting a case of 75 year old female presented with left level 3 cervical lymph node, whose final d...
HLA – B association in psoriasis
Background: Psoriasis is a common skin disorder with prevalence varying from 0% to 11.8% in different population. HLA association with psoriasis is well established with very little information about Indian Population. A...
International Journal of Medical Research and Review Available online at: www.ijmrr.in 2032 | P a g e HIV-associated peripheral neuropathies: a review
Objective: To review the various neurologic complications of HIV. Methods: A MEDLINE search of the Englishlanguage literature using a combination of words (HIV, neuropathy and diagnosis) was used to identify original stu...
Assessment of efficacy of IV ω-3 PUFA supplementation in patients of predicted severe acute pancreatitis using the positive predictive value of Balthazar score within 48 hours of onset
Introduction: Since 50% of the mortalities in acute pancreatitis (AP) occur within the first week, early prediction of its outcomes is vital. The CT severity index (CTSI) reliably predicts outcomes when calculated 4-7 da...